1. An update on viral-induced cutaneous lymphoproliferative disorders. CME Part I.
- Author
-
Plaza JA, Gru AA, Sangueza OP, Lourenco SV, Puccio FB, Sanches JA, Miyashiro D, Toussaint S, and Sangueza MJ
- Subjects
- Education, Medical, Continuing, Epstein-Barr Virus Infections, Lymphoma, T-Cell, Cutaneous pathology, Lymphoma, T-Cell, Cutaneous therapy, Lymphoma, T-Cell, Cutaneous virology, Skin Neoplasms pathology, Skin Neoplasms therapy, Skin Neoplasms virology, Hydroa Vacciniforme pathology, Hydroa Vacciniforme therapy, Leukemia-Lymphoma, Adult T-Cell pathology, Leukemia-Lymphoma, Adult T-Cell therapy, Lymphomatoid Granulomatosis pathology, Lymphomatoid Granulomatosis therapy, Lymphoproliferative Disorders pathology, Lymphoproliferative Disorders therapy, Lymphoproliferative Disorders virology, Skin Diseases pathology, Skin Diseases therapy, Skin Diseases virology
- Abstract
Viral-induced cutaneous T-cell lymphomas are an uncommon group of lymphoproliferative disorders characterized by a viral infection of T and natural killer (NK) cells. This group of cutaneous T-cell lymphomas is more commonly encountered in Asians and Native Americans from Central and South America compared with Western populations. Viral-associated lymphoproliferative disorders include a spectrum of entities that range from nonneoplastic lesions, such as chronic active Epstein-Barr virus infection and infective dermatitis to malignant diseases, such as extranodal NK/T-cell lymphoma, hydroa vacciniforme-like T-cell lymphoma, and adult T-cell leukemia/lymphoma. This review article will focus on hydroa vacciniforme-like lymphoproliferative disorder, extranodal NK/T-cell lymphoma, adult T-cell leukemia/lymphoma, lymphomatoid granulomatosis, and Epstein-Barr virus-positive mucocutaneous ulcers. We will review the pathogenesis of these conditions and the challenges of making a timely diagnosis in early-stage disease and discuss the common clinicopathologic manifestations, mutational landscape, and approaches to treat these highly aggressive and frequently lethal types of lymphoma., Competing Interests: Conflict of interest None disclosed., (Copyright © 2022 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF